OCRA News
Multimodal Study Uses Machine Learning to Improve Risk-Stratification of HGSOC
A recent study published in Nature Cancer talks about harnessing the power of machine learning to help predict prognosis and response to treatment for those with high-grade serous ovarian cancer (HGSOC)…
President Biden Appoints Cancer Panel Members and Cancer Cabinet Unveils Priority Actions
The following is a statement from The White House, published on July 13, 2022. Today, President Joe Biden announced his intent to appoint Dr. Mitchel Berger, Dr. Carol Brown, and Dr. Elizabeth Jaffee to the President’s Cancer Panel…
The Overview: July 2022
We hope everyone is enjoying some sunshine while keeping cool and hydrated…
House Appropriations Committee Approves FY23 Increases to Ovarian Cancer Programs Funding
In a promising development for our community, the House Appropriations Committee recently approved the fiscal year 2023 Labor, Health and Human Services, Education, and Related Agencies bill, which contains significant funding increases for key…
OCRA-Funded Study Reveals Promising Therapeutic Option for Boosting Ovarian Cancer Immune Response
Targeting a specific oncogene associated with the most common type of ovarian cancer may help increase a patient’s immune response to tumors, according to recent findings from researchers at The Wistar Institute and their colleagues at University…
Sertoli-Leydig Cell Ovarian Cancer | Jessica’s #RareAware Story
Jessica lives in Manassas, Virginia, and was diagnosed with Sertoli-Leydig cell ovarian cancer. What has been your frustration in having a rare form of ovarian cancer? It took over 8 years to get diagnosed…
The Overview: June 2022
We hope everyone is keeping cool while feeling the warmth from our ovarian cancer community…
OCRA’s 2022 National Conference
This event has now passed…
Letter to Senators Calling for Critical Reforms to Prescription Drug User Fee Act (PDUFA)
OCRA has joined 71 other organizations in signing on to a letter calling for the U.S…
New Bioinformatics Tool Shows Promise for Matching Cancer Patients with Optimal Treatment Combinations
Recent OCRA-funded research has resulted in the creation of a new bioinformatics tool that holds potential for predicting the best treatment combinations for cancer patients…
Sandra Cascio, PhD | Meet a Scientist
Dr. Sandra Cascio of Magee-Womens Research Institute is a 2021 recipient of OCRA’s Early Career Investigative Grant. With her project, “EGFL6 as a New Regulator of Myeloid Cell Expansion and Function in HGSOC,” Dr…
Streamers Unite to Say #GameOVAR to Ovarian Cancer
Calling all livestreamers … we need you! In the time of a 4-hour stream, 10 women are diagnosed with ovarian cancer. That’s a new diagnosis every 23 minutes…